Literature DB >> 20688036

High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence.

Olga A Maximova1, Brian R Murphy, Alexander G Pletnev.   

Abstract

Historically, the safety of live attenuated vaccine candidates against neurotropic viruses was assessed by semi-quantitative analysis of virus-induced histopathology in the central nervous system of monkeys. We have developed a high-throughput automated image analysis (AIA) for the quantitative assessment of virus-induced neuroinflammation and neurodegeneration. Evaluation of the results generated by AIA showed that quantitative estimates of lymphocytic infiltration, microglial activation, and neurodegeneration strongly and significantly correlated with results of traditional histopathological scoring. In addition, we show that AIA is a targeted, objective, accurate, and time-efficient approach that provides reliable differentiation of virus neurovirulence. As such, it may become a useful tool in establishing consistent analytical standards across research and development laboratories and regulatory agencies, and may improve the safety evaluation of live virus vaccines. The implementation of this high-throughput AIA will markedly advance many fields of research including virology, neuroinflammation, neuroscience, and vaccinology. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20688036      PMCID: PMC2997939          DOI: 10.1016/j.vaccine.2010.07.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

1.  Evaluation of the neurovirulence test for mumps vaccines.

Authors:  M A Afzal; S A Marsden; R M Hull; P A Pipkin; M L Bentley; P D Minor
Journal:  Biologicals       Date:  1999-03       Impact factor: 1.856

2.  Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.

Authors:  Alexander A Rumyantsev; Robert M Chanock; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2005-08-09       Impact factor: 3.641

3.  IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva.

Authors: 
Journal:  Biologicals       Date:  2005-10-28       Impact factor: 1.856

4.  Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

Authors:  Inessa Levenbook; Ken Draper
Journal:  J Virol       Date:  2009-05       Impact factor: 5.103

Review 5.  Viral encephalitis: a review of diagnostic methods and guidelines for management.

Authors:  I Steiner; H Budka; A Chaudhuri; M Koskiniemi; K Sainio; O Salonen; P G E Kennedy
Journal:  Eur J Neurol       Date:  2005-05       Impact factor: 6.089

6.  Characterization of the neuronal marker NeuN as a multiply phosphorylated antigen with discrete subcellular localization.

Authors:  Daniela Lind; Sebastian Franken; Joachim Kappler; Jakob Jankowski; Karl Schilling
Journal:  J Neurosci Res       Date:  2005-02-01       Impact factor: 4.164

7.  Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates.

Authors:  Olga A Maximova; Jerrold M Ward; David M Asher; Marisa St Claire; Brad W Finneyfrock; James M Speicher; Brian R Murphy; Alexander G Pletnev
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.

Authors:  Natalia S Pripuzova; Natalia V Tereshkina; Larissa V Gmyl; Tatiana I Dzhivanyan; Alexander A Rumyantsev; Lidiya Iu Romanova; Aida N Mustafina; Vasilii A Lashkevich; Galina G Karganova
Journal:  J Med Virol       Date:  2009-10       Impact factor: 2.327

9.  Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.

Authors:  Donald L Fine; Brian A Roberts; Sara J Terpening; Jason Mott; Daphne Vasconcelos; Robert V House
Journal:  Vaccine       Date:  2008-05-07       Impact factor: 3.641

10.  Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.

Authors:  J Erik Johnson; Farooq Nasar; John W Coleman; Roger E Price; Ali Javadian; Kenneth Draper; Margaret Lee; Patricia A Reilly; David K Clarke; R Michael Hendry; Stephen A Udem
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

View more
  4 in total

1.  Suppression of the motor deficit in a mucolipidosis type IV mouse model by bone marrow transplantation.

Authors:  Marquis T Walker; Craig Montell
Journal:  Hum Mol Genet       Date:  2016-06-07       Impact factor: 6.150

2.  Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo.

Authors:  Jonas Elias Schweig; Hailan Yao; Kyle Coppola; Chao Jin; Fiona Crawford; Michael Mullan; Daniel Paris
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

3.  Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss.

Authors:  Sergei Gaidamakov; Olga A Maximova; Hyongi Chon; Nathan H Blewett; Hongsheng Wang; Amanda K Crawford; Amanda Day; Natalie Tulchin; Robert J Crouch; Herbert C Morse; Robert D Blitzer; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

4.  Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis.

Authors:  Diane T Stephenson; Sharon M O'Neill; Sapna Narayan; Aadhya Tiwari; Elizabeth Arnold; Harry D Samaroo; Fu Du; Robert H Ring; Brian Campbell; Mathew Pletcher; Vidita A Vaidya; Daniel Morton
Journal:  Mol Autism       Date:  2011-05-16       Impact factor: 7.509

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.